0001695203-17-000001.txt : 20170119 0001695203-17-000001.hdr.sgml : 20170119 20170119161500 ACCESSION NUMBER: 0001695203-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170119 DATE AS OF CHANGE: 20170119 EFFECTIVENESS DATE: 20170119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Maverick Therapeutics Inc. CENTRAL INDEX KEY: 0001695203 IRS NUMBER: 814705784 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-278798 FILM NUMBER: 17536104 BUSINESS ADDRESS: STREET 1: 3260B BRISBANE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-443-7400 MAIL ADDRESS: STREET 1: 3260B BRISBANE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 D 1 primary_doc.xml X0707 D LIVE 0001695203 Maverick Therapeutics Inc. 3260B BAYSHORE BOULEVARD BRISBANE CA CALIFORNIA 94005 650-443-7400 DELAWARE None None Corporation true 2016 Luke Evnin 3260B Bayshore Boulevard Brisbane CA CALIFORNIA 94005 Director Bard Geesaman 3260B Bayshore Boulevard Brisbane CA CALIFORNIA 94005 Director Dan Hicklin 3260B Bayshore Boulevard Brisbane CA CALIFORNIA 94005 Director Hans Peter Gerber 3260B Bayshore Boulevard Brisbane CA CALIFORNIA 94005 Executive Officer Director Christopher Arendt 3260B Bayshore Boulevard Brisbane CA CALIFORNIA 94005 Director Lori Kunkel 3260B Bayshore Boulevard Brisbane CA CALIFORNIA 94005 Director Biotechnology Decline to Disclose 06b false 2017-01-06 false true true false 0 56000000 56000000 0 false 5 0 0 0 false Maverick Therapeutics Inc. /s/ Hans Peter Gerber Hans Peter Gerber Chief Science Officer and President 2017-01-19